Zobrazeno 1 - 10
of 26
pro vyhledávání: '"F C, Hamdy"'
Autor:
S. Sanghera, S. Mohiuddin, J. Coast, K. Garfield, S. Noble, C. Metcalfe, J. A. Lane, E. L. Turner, D. Neal, F. C. Hamdy, R. M. Martin, J. L. Donovan, for the ProtecT study group
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Optimal management strategies for clinically localised prostate cancer are debated. Using median 10-year data from the largest randomised controlled trial to date (ProtecT), the lifetime cost-effectiveness of three major treatment
Externí odkaz:
https://doaj.org/article/b0d3694fd50948e283224bb4b443f4c6
Autor:
Sanghera, S., S. Mohiuddin, J. Coast, K. Garfield, S. Noble, C. Metcalfe, J. A. Lane, E. L. Turner, D. Neal, F. C. Hamdy, R. M. Martin, J. L. Donovan
Additional file 1 Supplementary material. Contains supplementary data tables, labeled S1, S2 , S3 etc , used in the analysis of the different sub groups.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12d6044cd2ec167cd741b4a31f47a8b4
Autor:
R C, Macefield, C, Metcalfe, J A, Lane, J L, Donovan, K N L, Avery, J M, Blazeby, L, Down, D E, Neal, F C, Hamdy, K, Vedhara, Pauline, Thompson
Publikováno v:
British Journal of Cancer
BACKGROUND: When testing for prostate cancer, as many as 75% of men with a raised prostate-specific antigen (PSA) have a benign biopsy result. Little is known about the psychological effect of this result for these men. METHODS: In all, 330 men parti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e56759396c3b732c82a6fbf7b8e19d6e
https://ora.ox.ac.uk/objects/uuid:719c0267-e875-4b6c-a514-03849ebc16e9
https://ora.ox.ac.uk/objects/uuid:719c0267-e875-4b6c-a514-03849ebc16e9
Publikováno v:
British Journal of Cancer
Background: Recent evidence suggests that bone-related parameters are the main prognostic factors for overall survival in advanced prostate cancer (PCa), with elevated circulating levels of alkaline phosphatase (ALP) thought to reflect the dysregulat
Autor:
F C Hamdy
Publikováno v:
TumorDiagnostik & Therapie. 38:218-218
Autor:
E L, Turner, C, Metcalfe, J L, Donovan, S, Noble, J A C, Sterne, J A, Lane, K N, Avery, L, Down, E, Walsh, M, Davis, Y, Ben-Shlomo, S E, Oliver, S, Evans, P, Brindle, N J, Williams, L J, Hughes, E M, Hill, C, Davies, S Y, Ng, D E, Neal, F C, Hamdy, R M, Martin
Publikováno v:
British Journal of Cancer
Background: Screening for prostate cancer continues to generate controversy because of concerns about over-diagnosis and unnecessary treatment. We describe the rationale, design and recruitment of the Cluster randomised triAl of PSA testing for Prost
Publikováno v:
The Prostate. 73(4)
Dystroglycan is a ubiquitously expressed cell adhesion molecule frequently found to be altered or reduced in adenocarcinomas, however the mechanisms or consequences of dystroglycan loss have not been studied extensively.We examined the consequence of
Autor:
F C, Hamdy, M, Rouprêt
Publikováno v:
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 18
The PCPT trial is the first phase III trial with the principal objective of examining the hypothesis that the use of chemoprevention could prevent the development of prostate cancer. This is a large scale randomised clinical trial comparing finasteri
Publikováno v:
The Journal of pathology. 214(3)
Bone morphogenetic protein-6 (BMP-6) has been strongly implicated in prostate cancer development and bone metastasis. Our previous data showed that BMP-6 mRNA was absent in patients with benign prostatic hyperplasia, but evident in primary tumours wi